amsys 16(12): e5

Research Article

ICT Based Diabetes Management System with Comprehensive Mobile Application: Clinical Usefulness Evaluation

Download1078 downloads
  • @ARTICLE{10.4108/eai.14-10-2015.2261966,
        author={Fedor Lehocki and Peter Jackuliak and Eva Žakovičov\^{a} and Tom\^{a}š Bacigal},
        title={ICT Based Diabetes Management System with Comprehensive Mobile Application: Clinical Usefulness Evaluation},
        journal={EAI Endorsed Transactions on Ambient Systems},
        volume={3},
        number={12},
        publisher={ACM},
        journal_a={AMSYS},
        year={2015},
        month={12},
        keywords={mhealth, telemedicine, telehealth, diabetes, clinical study},
        doi={10.4108/eai.14-10-2015.2261966}
    }
    
  • Fedor Lehocki
    Peter Jackuliak
    Eva Žakovičová
    Tomáš Bacigal
    Year: 2015
    ICT Based Diabetes Management System with Comprehensive Mobile Application: Clinical Usefulness Evaluation
    AMSYS
    EAI
    DOI: 10.4108/eai.14-10-2015.2261966
Fedor Lehocki1,*, Peter Jackuliak2, Eva Žakovičová3, Tomáš Bacigal1
  • 1: Slovak University of Technology in Bratislava
  • 2: Comenius University, Faculty of Medicine
  • 3: Diacrin Diabetes and Endocrinology Clinic
*Contact email: fedor.lehocki@stuba.sk

Abstract

Objective of the presented study is to introduce telemedicine system that integrates all of the most implemented features that appear in different mobile diabetes applications in addition to blood glucose: tracking of insulin or other medications, communication, diet management, physical activity, weight, blood pressure, personal health record, education, social media, and alerts. Presented telemedicine system employs these features for management of Type 1 and Type 2 diabetes patients. Clinical evaluation after 3 months of intervention showed change of HbA1c in both patient groups was not only statistical significant but it had also a clinical dimension. The HbA1c decreased by 0,5% represents significant change for reduction of diabetic complications. Baseline for HbA1c in 29 T1DM patients: 8.1±1.5% versus 7.5±1.2% (P = 0.008). Baseline for HbA1c in 26 T2DM patients: 7.4±1.2% versus 6.8±1.1% (p=0.001). Results show statistically significant tendency to decrease in T2DM patients in weight 93.2±13.6kg compared to 91.9±14.2kg (P=0.08); and BMI 30.7±4.1 kg/m2 compared to 30.2±4.2 kg/m2 (P=0.08).